Relative therapeutic index between inhaled formoterol and salbutamol in asthma patients
- 30 June 2002
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 96 (6) , 412-417
- https://doi.org/10.1053/rmed.2002.1291
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potencyEuropean Respiratory Journal, 1997
- Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients.Thorax, 1995
- Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.Thorax, 1995
- Comparison of terbutaline and placebo from a pressurised metered dose inhaler and a dry powder inhaler in a subgroup of patients with asthma.Thorax, 1994
- Why are long-acting beta-adrenoceptor agonists long-acting?European Respiratory Journal, 1994
- Effects of β‐adrenoceptor agonists in human bronchial smooth muscleBritish Journal of Pharmacology, 1993
- Inhaled beta 2‐adrenoceptor agonists in asthma: help or hindrance?British Journal of Clinical Pharmacology, 1992
- Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthmaThe Lancet, 1990
- Formoterol fumarate, a new β2‐adrenoceptor agonistAllergy, 1989
- Standardization of Spirometry—1987 UpdateAmerican Review of Respiratory Disease, 1987